Powered By Blogger

10.18.2011

rare disease that




While asleep, Haley went into cardiac arrest, stopped breathing and never started again, concluded the medical examiner in Ft. Myers, Fla. The examiner found that a thickened artery wall had blocked blood flow to Haley's heart. The odd growth of the artery wall suggested the presence of a disease called FMD, or fibromuscular dysplasia, the examiner concluded.
Andrew Spear for The Wall Street Journal
Patients Pam Mace, left, and Rochelle DesRochers with Dr. Jeffrey Olin, who says FMD is more common than thought.
FMD, a condition in which artery walls expand into and obstruct the arterial channel, is largely unknown to the public and even to the majority of doctors. When discussed in medical schools -- if discussed at all -- FMD is typically described as an obscure and rare disease.
Yet a tantalizing body of evidence has begun to emerge that suggests FMD isn't rare at all: It simply isn't looked for, so it is seldom diagnosed.
Some FMD patients aren't diagnosed even after arriving in doctors' offices with such severe events as strokes; burst aneurysms, or ballooned sections of arteries; and artery dissections, in which the inner artery lining peels away and hampers blood flow. Some FMD patients say they get dismissed by doctors who, rather than admit they don't understand what is wrong, tell patients that their problems are psychosomatic.
A few thousand cases of FMD have been confirmed in the U.S., mostly during the last decade. The National Stroke Association in 2005 listed FMD as a cause of strokes. This year, a group of vascular specialists across the U.S. started a computerized registry of patients to analyze FMD's scope, causes and treatments.
"I believe that a large number of Americans have FMD," says Jeffrey W. Olin, director of vascular medicine and a professor at the Mt. Sinai School of Medicine in New York City. "It's reasonable to say that many thousands could be saved from complications like heart attack, stroke, ruptured aneurysm and even death, by screening patients."
[fibro]
There have been clues to FMD's scope for years. In one series of random consecutive autopsies at the Mayo Clinic in Rochester, Minn., in the 1970s, nine, or more than 1%, of 819 patients had FMD. In a separate, 1989 study of 1,862 patients who volunteered to donate kidneys, 71, or 3.8%, were found through scans of their renal arteries to have FMD. This year in the European Journal of Radiology, a study of 101 potential kidney donors found an almost identical rate -- four patients, or 3.9%.
"Three to five percent would be a very reasonable estimate in the general population for FMD," says Thom W. Rooke, vascular medicine professor at the Mayo Clinic. That works out to there being possibly 10 million Americans who have FMD, he says. By comparison, an estimated 3 million Americans have epilepsy, 2.5 million have breast cancer, more than 2 million have schizophrenia and 725,000 have melanoma.
Dr. Rooke says many FMD patients might never have symptoms, and only a few are likely to experience severe problems. But, he says, many "vascular catastrophes," such as heart-rhythm deaths and strokes in young people, may stem from FMD.
About 85% of the known FMD cases have affected women under 50 and girls, but boys and men also get it. It is not clear how the disease originates, though one French study reports that more than 10% of patients have close relatives with FMD. Dr. Olin says it is more like 5% in his patients. Last year, the National Institutes of Health identified several genes possibly linked to FMD.
FMD was first described in a medical journal in 1938, but until roughly the past decade, publications described only isolated, individual cases. Vascular-medicine doctors, who specialize in diseases of the arteries and veins, generally say they received no information about it in medical schools. The field of vascular medicine itself is relatively small, with only a few hundred doctors, plus over 2,000 surgeons, practicing in the U.S. In contrast, there are roughly 25,000 cardiologists.
Research on FMD is scant, partly because the pharmaceutical industry hasn't envisioned potentially large profits. Current treatments include blood-pressure and anti-clotting drugs, and angioplasty to open arteries.
Dr. Olin, 58 years old, began gravitating toward vascular medicine during a residency at the Cleveland Clinic in the early 1980s. Because the clinic is mostly a referral hospital, meaning doctors send patients there when they can't figure out what is wrong, he was exposed to obscure vascular diseases.

A Rare Disease That May Be Underdiagnosed

3:50
Fibromuscular dysplasia, which causes artery walls to expand into and obstruct arteries, is largely unknown to the public and even to a majority of doctors. Evidence suggests FMD might not be rare, it just isn't looked for. Tom Burton reports.
These days, he is known among colleagues as much for his FMD research as for his repeated wins at "Vascular Jeopardy," a trivia game played every year at a meeting of vascular specialists.
While still at the Cleveland Clinic in the early 1990s, Dr. Olin encountered a 29-year-old patient who made a lasting impression. Lori Gardner, vibrant and otherwise in good health, had had a series of mini-strokes, constant fatigue and headaches, and a sky-high blood pressure of 250 over 150. Her doctors, she recalls now, had told her she had "stress."
"I'd been through so many doctors who didn't have the time for me," she says. Dr. Olin performed scans of the carotid arteries in her neck and renal arteries, those that supply her kidneys, and found FMD. When FMD is present, the artery lining pushes into the artery channel, while adjacent artery sections often bulge out in an alternating pattern. On an imaging scan, an affected artery often looks eerily like a string of beads.
Dr. Olin told Ms. Gardner she had FMD. Scans of the renal arteries and carotid arteries in the neck wouldn't normally be done unless doctors were investigating other possible diseases, yet they are the most definitive way to diagnose FMD. High blood pressure in patients under the age of 35 is another red flag, say doctors.
Many vascular-medicine doctors say they weren't taught about FMD in medical school, but some schools say they address it. At the Yale School of Medicine, Deputy Dean for Education Richard Belitsky says FMD is included in a second-year class on the kidneys and during a third-year primary-care rotation.
By the late-1990s, Dr. Olin was publishing his findings about patients with FMD, including treatments that tended to work. As he published, more FMD patients kept arriving at his doorstep.
Others were referred by Pam Mace, an FMD patient herself. Now president of the FMD Society of America, Ms. Mace is an emergency-room nurse from the Cleveland area who lives today in Grosse Ile, Mich. Slim and athletic, Ms. Mace was running marathons until 2000. In July 2000, she awoke with a headache. She later looked in a mirror and noticed dramatically unequal pupils, which she knew could indicate a stroke. One side of her face was numb.
At the emergency room, Ms. Mace says, her blood pressure read a disturbingly high 210 over 130. But it took three visits to two hospitals to conclusively diagnose that she had dissections, or major tears, in the lining of arteries supplying her brain. Even then, FMD wasn't diagnosed and treated until the following year.
One of the patients Ms. Mace later referred to Dr. Olin was Bruce Tagg, 54. An insurance safety consultant from Allentown, Pa., Mr. Tagg was suffering severe pain in his left flank two years ago. He was vomiting, had a fever of 102 degrees for six weeks and showed high blood pressure. Doctors gave him antibiotics.
But he didn't have an infection. Even after an image showed the characteristic beading in one renal artery, doctors "totally missed a dissection" in the other, says Dr. Olin. "The kidney was infarcting, meaning it was dying," because the renal artery was blocked off. Now, after angioplasty, a process that pushes the walls of the artery back out using a tiny balloon, Mr. Tagg is in better health, despite the death of extensive kidney tissue.
Even when FMD is correctly diagnosed, doctors can make mistakes with treatment. In October 2007, doctors found a blockage in Rochelle DesRochers's renal artery. She was 45 years old, and told she had FMD. She says she brought literature to her doctor showing that the use of stents for such a blockage was generally a bad idea with FMD. "We do this all the time," she recalls her doctor saying. He placed a metal stent in her renal artery, she says.
"Forty-five minutes into recovery, I started feeling pain," she says. Doctors found the artery had dissected, or torn, and was further blocking blood flow to the kidneys. They put in another stent to try to reopen the artery. Within days, despite being in a lot of pain, she was sent home by doctors. It turned out that the now-dissected artery had thrown a blood clot into her kidney. She now is being treated by Dr. Olin, who says a stent was the wrong procedure and that it probably caused the clot and death of extensive kidney tissue.
Not all patients get diagnosed during their lifetimes. Haley McWhorter, the 10-year-old whose autopsy suggested FMD, had dizziness and headaches in her final weeks. Her mother, Laura Lemus, says she took Haley to a pediatrician, who said there was no reason to suspect a severe illness. "He said it was nothing, and that I didn't have anything to worry about," says Ms. Lemus.
Dr. Olin says that while Haley's symptoms could have been signs of the disease, they also could have been interpreted as any number of other things. Ms. Lemus says Haley's siblings have been tested but no FMD was found.
In another case, Adam Nickel, 27, had suffered no symptoms before he collapsed March 1, 2008, after finishing a marathon in Little Rock, Ark., his mother says. Like Haley, he died of sudden cardiac arrest from FMD, says Stephen Erickson, the medical examiner who did the autopsy.
Dr. Olin has prepared a top-10 list of doctors' misconceptions and missteps. They include, "Telling patients that the symptoms are all in their head. Telling patients that FMD is a rare disease. Telling patients with severe headaches with FMD that there is nothing that you can do for them."
The signs of FMD are frequently the same: young patients with high blood pressure, or who have had a stroke or temporary symptoms of a stroke; patients whose blood makes a swishing sound indicating turbulent flow; or patients with brain aneurysms.
Last year, doctors started an FMD registry to compile basic information: How many patients have immediate family with the disease? Why do only some patients suffer strokes or artery dissections? Will a symptom-free patient necessarily stay that way?
The registry began enrolling patients in January. One, Michigan resident Shawn Haven, was first diagnosed at the Mayo Clinic by vascular specialist Robert McBane. The lesson from Ms. Haven's case: Some doctors don't think to use a stethoscope.
Ms. Haven, now 45, went to a doctor in Michigan in October 2007 with severe abdominal pain and high blood pressure. She was very thin and unable to gain weight.
By early 2008, she says, she had "horrific pain" in the stomach and went to the emergency room. Two doctors, she says, concluded her problems were in her head. She recalls one of them telling her, "Just look at you, you're trying to make yourself sick."
Ms. Haven and her husband flew to the Mayo Clinic, where a doctor put a stethoscope to her abdomen. He heard a whooshing sound that indicates artery blockage and turbulent blood flow. Soon after, Dr. McBane found that FMD was blocking arteries to Ms. Haven's upper intestine, spleen and liver. The upper-intestine blockage led to the pain.
Though the arteries have since been cleared, doctors say Ms. Haven continues to deal with symptoms from artery blockage. She says she has to stick to a bland diet and is in near-constant pain: "I am going to be living with this for the rest of my life."


Reviewed February 2008

What is diastrophic dysplasia?

Diastrophic dysplasia is a disorder of cartilage and bone development. Affected individuals have short stature with very short arms and legs. Most also have early-onset joint pain (osteoarthritis) and joint deformities called contractures, which restrict movement. These joint problems often make it difficult to walk and tend to worsen with age. Additional features of diastrophic dysplasia include an inward- and upward-turning foot (clubfoot), progressive abnormal curvature of the spine, and unusually positioned thumbs (hitchhiker thumbs). About half of infants with diastrophic dysplasia are born with an opening in the roof of the mouth (a cleft palate). Swelling of the external ears is also common in newborns and can lead to thickened, deformed ears.
The signs and symptoms of diastrophic dysplasia are similar to those of another skeletal disorder called atelosteogenesis type 2; however, diastrophic dysplasia tends to be less severe. Although some affected infants have breathing problems, most people with diastrophic dysplasia live into adulthood.
Read more about atelosteogenesis type 2.

How common is diastrophic dysplasia?

Although the exact incidence of this condition is unknown, researchers estimate that it affects about 1 in 100,000 newborns. Diastrophic dysplasia occurs in all populations but appears to be particularly common in Finland.

What genes are related to diastrophic dysplasia?

Diastrophic dysplasia is one of several skeletal disorders caused by mutations in the SLC26A2 gene. This gene provides instructions for making a protein that is essential for the normal development of cartilage and for its conversion to bone. Cartilage is a tough, flexible tissue that makes up much of the skeleton during early development. Most cartilage is later converted to bone, except for the cartilage that continues to cover and protect the ends of bones and is present in the nose and external ears. Mutations in theSLC26A2 gene alter the structure of developing cartilage, preventing bones from forming properly and resulting in the skeletal problems characteristic of diastrophic dysplasia.
Read more about the SLC26A2 gene.

How do people inherit diastrophic dysplasia?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Where can I find information about diagnosis, management, or treatment of diastrophic dysplasia?

These resources address the diagnosis or management of diastrophic dysplasia and may include treatment providers.
You might also find information on the diagnosis or management of diastrophic dysplasia in Educational resources and Patient support.
To locate a healthcare provider, see How can I find a genetics professional in my area? in the Handbook.

Where can I find additional information about diastrophic dysplasia?

You may find the following resources about diastrophic dysplasia helpful. These materials are written for the general public.
You may also be interested in these resources, which are designed for healthcare professionals and researchers.

What other names do people use for diastrophic dysplasia?

  • Diastrophic dwarfism
  • DTD
For more information about naming genetic conditions, see the Genetics Home Reference Condition Naming Guidelines and How are genetic conditions and genes named? in the Handbook.

What if I still have specific questions about diastrophic dysplasia?

Where can I find general information about genetic conditions?

What glossary definitions help with understanding diastrophic dysplasia?



On this page:

What is Barrett's esophagus?

Barrett's esophagus is a condition in which the tissue lining the esophagus—the muscular tube that connects the mouth to the stomach—is replaced by tissue that is similar to the lining of the intestine. This process is called intestinal metaplasia.
No signs or symptoms are associated with Barrett's esophagus, but it is commonly found in people with gastroesophageal reflux disease (GERD). A small number of people with Barrett's esophagus develop a rare but often deadly type of cancer of the esophagus.
Barrett's esophagus affects about 1 percent1 of adults in the United States. The average age at diagnosis is 50, but determining when the problem started is usually difficult. Men develop Barrett's esophagus twice as often as women, and Caucasian men are affected more frequently than men of other races. Barrett's esophagus is uncommon in children.

The Esophagus

The esophagus carries food and liquids from the mouth to the stomach. The stomach slowly pumps the food and liquids into the intestine, which then absorbs needed nutrients. This process is automatic and people are usually not aware of it. People sometimes feel their esophagus when they swallow something too large, try to eat too quickly, or drink very hot or cold liquids.
Drawing of the digestive tract with labels pointing to the mouth, esophagus, stomach, small intestine, ileum, large intestine (colon), rectum and anus.
Digestive tract.
The muscular layers of the esophagus are normally pinched together at both the upper and lower ends by muscles called sphincters. When a person swallows, the sphincters relax to allow food or drink to pass from the mouth into the stomach. The muscles then close rapidly to prevent the food or drink from leaking out of the stomach back into the esophagus and mouth.
1Cameron AJ. Epidemiology of Barrett's esophagus and adenocarcinoma. Diseases of the Esophagus. 2002;15:106–108.
[Top]

What is gastroesophageal reflux disease (GERD)?

GERD is a more serious form of gastroesophageal reflux (GER). GER occurs when the lower esophageal sphincter opens spontaneously for varying periods of time or does not close properly and stomach contents rise into the esophagus. GER is also called acid reflux or acid regurgitation because digestive juices called acids rise with the food or fluid.
When GER occurs, food or fluid can be tasted in the back of the mouth. When refluxed stomach acid touches the lining of the esophagus it may cause a burning sensation in the chest or throat called heartburn or acid indigestion. Occasional GER is common and does not necessarily mean one has GERD.
Persistent reflux that occurs more than twice a week is considered GERD and can eventually lead to more serious health problems. Overall, 10 to 20 percent2 of Americans experience GERD symptoms every day, making it one of the most common medical conditions. People of all ages can have GERD.
GERD symptoms are often relieved by over-the-counter, acid-reducing agents called antacids. Common antacids include
  • Alka-Seltzer
  • Maalox
  • Mylanta
  • Pepto-Bismol
  • Riopan
  • Rolaids
Other drugs used to relieve GERD symptoms are anti-secretory drugs such as H2 blockers and proton pump inhibitors. Common H2 blockers are
  • cimetidine (Tagamet HB)
  • famotidine (Pepcid AC)
  • nizatidine (Axid AR)
  • ranitidine (Zantac 75)
Common proton pump inhibitors are
  • esomeprazole (Nexium)
  • lansoprazole (Prevacid)
  • omeprazole (Prilosec, Zegerid)
  • pantoprazole (Protonix)
  • rabeprazole (Aciphex)
People who have GERD symptoms should consult with a physician. If GERD is left untreated over a long period of time, it can lead to complications such as a bleeding ulcer. Scars from tissue damage can lead to strictures—narrowed areas of the esophagus—that make swallowing difficult. GERD may also cause hoarseness, chronic cough, and conditions such as asthma.

GERD and Barrett's Esophagus

The exact causes of Barrett's Esophagus are not known, but GERD is a risk factor for the condition. Although people who do not have GERD can have Barrett's Esophagus, the condition is found about three to five times more often in people who also have GERD.
Since Barrett's Esophagus is more commonly seen in people with GERD, most physicians recommend treating GERD symptoms with acid-reducing drugs.
Improvement in GERD symptoms may lower the risk of developing Barrett's Esophagus. A surgical procedure may be recommended if medications are not effective in treating GERD.
2El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clinical Gastroenterology and Hepatology. 2007;5(1):17–26.
[Top]

How is Barrett's esophagus diagnosed?

Because Barrett's esophagus does not cause any symptoms, many physicians recommend that adults older than 40 who have had GERD for a number of years undergo an endoscopy and biopsies to check for the condition.
Drawing of a microscopic piece of the esophagus showing normal tissue.
Normal esophagus.
Drawing of a microscopic piece of the esophagus showing the abnormal tissue of Barrett's esophagus.
Barrett's esophagus.
Barrett's esophagus can only be diagnosed using an upper gastrointestinal (GI) endoscopy to obtain biopsies of the esophagus. In an upper GI endoscopy, after the patient is sedated, the doctor inserts a flexible tube called an endoscope, which has a light and a miniature camera, into the esophagus. If the tissue appears suspicious, the doctor removes several small pieces using a pincher-like device that is passed through the endoscope. A pathologist examines the tissue with a microscope to determine the diagnosis.
[Top]

What is the risk of esophageal cancer with Barrett's esophagus?

People with Barrett's esophagus have a low risk of developing a kind of cancer called esophageal adenocarcinoma. Less than 1 percent3 of people with Barrett's esophagus develop esophageal adenocarcinoma each year. Barrett's esophagus may be present for several years before cancer develops. Esophageal adenocarcinoma is frequently not detected until its later stages when treatments are not always effective.

Surveillance for Dysplasia and Cancer

Periodic endoscopic examinations with biopsies to look for early warning signs of cancer are generally recommended for people who have Barrett's esophagus. This approach is called surveillance.
Typically, before esophageal cancer develops, precancerous cells appear in the Barrett's tissue. This condition is called dysplasia and can be seen only through biopsies. Multiple biopsies must be taken because dysplasia can be missed in a single biopsy. Detecting and treating dysplasia may prevent cancer from developing.
3Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett's esophagus, and esophageal cancer.Journal of the American Medical Association. 2002;287(15):1982–1986.
[Top]

How is Barrett's esophagus with dysplasia or cancer treated?

Endoscopic or surgical treatments can be used to treat Barrett's esophagus with severe dysplasia or cancer. Your doctor will present the available options and help determine the best course of treatment for you.

Endoscopic Treatments

Several endoscopic therapies are available to treat severe dysplasia and cancer. During these therapies, the Barrett's lining is destroyed or the portion of the lining that has dysplasia or cancer is cut out. The goal of the treatment is to encourage normal esophageal tissue to replace the destroyed Barrett's lining. Endoscopic therapies are performed at specialty centers by physicians with expertise in these procedures.
  • Photodynamic Therapy (PDT). PDT uses a light-sensitizing agent called Photofrin and a laser to kill precancerous and cancerous cells. Photofrin is injected into a vein and the patient returns 48 hours later. The laser light is then passed through the endoscope and activates the Photofrin to destroy Barrett's tissue in the esophagus. Complications of PDT include chest pain, nausea, sun sensitivity for several weeks, and esophageal strictures.
  • Endoscopic Mucosal Resection (EMR). EMR involves lifting the Barrett's lining and injecting a solution under it or applying suction to it and then cutting it off. The lining is then removed through the endoscope. If EMR is used to treat cancer, an endoscopic ultrasound is done first to make sure the cancer involves only the top layer of esophageal cells. The ultrasound uses sound waves that bounce off the walls of the esophagus to create a picture on a monitor. Complications of EMR can include bleeding or tearing of the esophagus. EMR is sometimes used in combination with PDT.

Surgery

Surgical removal of most of the esophagus is recommended if a person with Barrett's esophagus is found to have severe dysplasia or cancer and can tolerate a surgical procedure. Many people with Barrett's esophagus are older and have other medical problems that make surgery unwise; in these people, the less-invasive endoscopic treatments would be considered. Surgery soon after diagnosis of severe dysplasia or cancer may provide a person with the best chance for a cure. The type of surgery varies, but it usually involves removing most of the esophagus, pulling a portion of the stomach up into the chest, and attaching it to what remains of the esophagus.
[Top]

Points to Remember

  • In Barrett's esophagus, the tissue lining the esophagus is replaced by tissue that is similar to the lining of the intestine.
  • Barrett's esophagus is associated with gastroesophageal reflux disease (GERD).
  • Improvement in GERD symptoms with acid-reducing drugs may decrease the risk of developing Barrett's esophagus.
  • Barrett's esophagus is diagnosed through an upper gastrointestinal endoscopy and biopsies.
  • People who have Barrett's esophagus should have periodic surveillance endoscopies and biopsies.
  • Endoscopic treatments are used to destroy Barrett's tissue, which will hopefully be replaced with normal esophageal tissue.
  • Removal of most of the esophagus is recommended if a person with Barrett's esophagus is found to have severe dysplasia or cancer and can tolerate a surgical procedure.
[Top]

Hope through Research

The National Institute for Diabetes and Digestive and Kidney Diseases and the National Cancer Institute sponsor research programs to investigate Barrett's esophagus and esophageal adenocarcinoma.
Further research into Barrett's esophagus is needed, including
  • establishing additional tests to identify people with Barrett's esophagus
  • identifying the cause(s) of Barrett's esophagus
  • studying the long-term effectiveness of treatments such as PDT and EMR
  • developing additional nonsurgical treatments for people who have Barrett's esophagus and dysplasia or cancer
Participants in clinical trials can play a more active role in their own health care, gain access to new research treatments before they are widely available, and help others by contributing to medical research. For information about current studies, visit www.ClinicalTrials.gov.
The U.S. Government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in this document are used only because they are considered necessary in the context of the information provided. If a product is not mentioned, the omission does not mean or imply that the product is unsatisfactory.
[Top]

For More Information

American Gastroenterological Association
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: 301–654–2055
Fax: 301–654–5920
Email: member@gastro.org
Internet: www.gastro.orgleaving site icon
International Foundation for Functional Gastrointestinal Disorders
P.O. Box 170864
Milwaukee, WI 53217
Phone: 1–888–964–2001 or 414–964–1799
Fax: 414–964–7176
Email: iffgd@iffgd.org
Internet: www.iffgd.orgleaving site icon
National Cancer Institute
National Institutes of Health
6116 Executive Boulevard, Room 3036A
Bethesda, MD 20892–8322
Phone: 1–800–4–CANCER (422–6237)
Fax: 301–496–0846
Email: cancergovstaff@mail.nih.gov
Internet: www.cancer.gov
You may also find additional information about this topic by visiting MedlinePlus atwww.medlineplus.gov.
This publication may contain information about medications. When prepared, this publication included the most current information available. For updates or for questions about any medications, contact the U.S. Food and Drug Administration toll-free at 1–888–INFO–FDA (1–888–463–6332) or visit www.fda.gov. Consult your doctor for more information.
[Top]

National Digestive Diseases Information Clearinghouse

2 Information Way
Bethesda, MD 20892–3570
Phone: 1–800–891–5389
TTY: 1–866–569–1162
Fax: 703–738–4929
Email: nddic@info.niddk.nih.gov
Internet: www.digestive.niddk.nih.gov
The National Digestive Diseases Information Clearinghouse (NDDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health of the U.S. Department of Health and Human Services. Established in 1980, the Clearinghouse provides information about digestive diseases to people with digestive disorders and to their families, health care professionals, and the public. The NDDIC answers inquiries, develops and distributes publications, and works closely with professional and patient organizations and Government agencies to coordinate resources about digestive diseases.
Publications produced by the Clearinghouse are carefully reviewed by both NIDDK scientists and outside experts. This publication was reviewed by G. Richard Locke, M.D., Mayo Clinic, and Joel Richter, M.D., Cleveland Clinic Foundation.
This publication is not copyrighted. The Clearinghouse encourages users of this publication to duplicate and distribute as many copies as desired.

NIH Publication No. 08–4546

About Us

wood river, il, United States
http://joknows.bigcartel.com/about-us About Us You'll find everything from licensed band tees, rockabilly retro clothing, and accessories. We also have a revolving variety of women & juniors clothing that we get at closeout prices. Those are get them while you can, we pass our savings onto you. Sourpuss brand is our favorite and you will always find their latest and greatest. We carry forever 21 and Hot Topic items as well. Music lovers should check us out for the band and concert wear. As well as our unique accessories. Various styles of jewelry, purses and wallets. Baby diaper bags, onesies and bibs that will not find elsewhere. Licensed diaper bags from Johnny Cash, AC/DC, the Misfits and Sex Pistols just to name a few. Original Tattoo artwork tee shirts for men are authentic must haves. We have some great accessories and household items geared toward Hot Rod Vintage and Tattoo inspired lovers. Check out our bar and lounge items even if you're not a drinker! We are starting to carry Sailor Jerry merchandise, the real authentic only. Check us out we are here for all of our loyal customers and future customers.